Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · IEX Real-Time Price · USD
6.89
+0.07 (1.03%)
At close: Jul 19, 2024, 12:00 AM
7.07
+0.18 (2.61%)
Pre-market: Jul 22, 2024, 9:10 AM EDT
Verve Therapeutics Employees
Verve Therapeutics had 255 employees as of December 31, 2023. The number of employees increased by 51 or 25.00% compared to the previous year.
Employees
255
Change (1Y)
51
Growth (1Y)
25.00%
Revenue / Employee
$62,937
Profits / Employee
-$771,878
Market Cap
578.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 255 | 51 | 25.00% |
| Dec 31, 2022 | 204 | 91 | 80.53% |
| Dec 31, 2021 | 113 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Varex Imaging | 2,400 |
| Emergent BioSolutions | 1,600 |
| Pharming Group | 382 |
| Alector | 244 |
| Allogene Therapeutics | 233 |
| iTeos Therapeutics | 157 |
| GH Research | 49 |
VERV News
- 2 hours ago - Verve Therapeutics, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details- VERV - Accesswire
- 2 days ago - Shareholders that lost money on Verve Therapeutics, Inc.(VERV) should contact Levi & Korsinsky about Securities Fraud Investigation - VERV - Accesswire
- 2 days ago - Verve Therapeutics Incorporated Is Under Investigation By The Schall Law Firm And Investors With Losses Are Urged To Connect - Accesswire
- 3 days ago - Verve Therapeutics, Inc. (VERV) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - Accesswire
- 3 days ago - The Schall Law Firm Is Investigating Verve Therapeutics Incorporated And Encourages Investors With Losses To Reach Out - Accesswire
- 4 days ago - Shareholder Rights Advocates at Levi & Korsinsky Investigate Verve Therapeutics, Inc. (VERV) Regarding Possible Securities Fraud Violations - Accesswire
- 4 days ago - The Schall Law Firm Is Conducting An Investigation Into Verve Therapeutics Inc And Encourages Investors Who Have Incurred Losses To Reach Out - Accesswire
- 5 days ago - Levi & Korsinsky Reminds Shareholders of an Investigation into Verve Therapeutics, Inc. (VERV) Regarding Potential Securities Fraud Allegations - Accesswire